Connecta Therapeutics

unknown
unknown
Stage

About

Connecta Therapeutics is a clinical-stage biotech company developing innovative treatments for central nervous system (CNS) disorders, with clinical programs focusing on neurodevelopmental conditions such as Fragile X Syndrome.

Explore Connecta Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.